Skip to main content

Breadcrumb

  1. Home

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder

Corrona Inflammatory Bowel Disease (IBD) Registry

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Corrona Inflammatory Bowel Disease (IBD) Registry

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

Electronic Patient Reporting of Symptoms During Cancer Treatment

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Electronic Patient Reporting of Symptoms During Cancer Treatment

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With Advanced Urothelial Cancer and Selected Fibroblast Growth Factor Receptor (FGFR) Gene Aberrations

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Movement Intervention for Memory Enhancement

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Movement Intervention for Memory Enhancement

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 236
  • Page 237
  • Page 238
  • Page 239
  • Page 240
  • Page 241
  • Page 242
  • Page 243
  • Page 244
  • …
  • Next page Next
  • Last page Last
Subscribe to